Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by scaleyon Jun 28, 2020 7:50pm
1945 Views
Post# 31201169

Release the hounds Smithers

Release the hounds Smithers I expect this news / halt release Monday or Wednesday. It's going to be good obviously and then the share price will increase accordingly. Fifteen cents isn't too far away. Then watch out. The possibility's here are ridiculous. The next 3 weeks will set the stage for the next year. This stock is the real deal, it's taking time, but your  wait and stress will be rewarded. It's not going under, so don't listen to the bashing. When you invest in a stock, it's because you believe you are making your best investment at your chosen price.   If you listen to people without doing your own dd, you will make a bad investment a usually lose your cash. Then you're bitter. When you go in with confidence, and educated, it's an easier and less stressful wait, that's the difference . The wait hasn't worried me at all. Because I did my research. Any who, take a deep breath, chill out, and let this take its path to success. It'll come. 
<< Previous
Bullboard Posts
Next >>